Abstract 5810: Distinct mechanisms of CD28 and 4-1BB costimulation in glofitamab combination therapies for relapsed/refractory non-Hodgkin lymphoma (R/R NHL)
Year: 2025
Type: conference-abstract
Source: Cancer Research
Authors: Koorosh Korfi, Zhiwen Jiang, Sabine Wilson, Ailsa Christiansen, Wilfred Leung, Katharina Lechner, Natalie Dimier, Philip Knuckles, Kat Reyskens, Iva Lelios, Annika Blank, Alexandra Epp, Sylvia Herter, Johannes Sam, Paolo Caimi, Lorenzo Falchi, Roch Houot, Fritz Offner, Harriet Walter, Herve Ghesquieres, Guillaume Cartron, William Townsend, Giuseppe Gritti, Francesc Bosch, Michael Dickinson, Carmelo Carlo-Stella, Martin Hutchings, Franck Morschhauser
Institutions: Roche (Switzerland), Roche (United Kingdom), Sands, Genentech, Cleveland Clinic, Memorial Sloan Kettering Cancer Center, Centre Hospitalier Universitaire de Rennes, Ghent University Hospital, University of Leicester, University Hospitals of Leicester NHS Trust, Hospices Civils de Lyon, Hôpital Lyon Sud, Centre Hospitalier Universitaire de Montpellier, University College London Hospitals NHS Foundation Trust, Ospedale Papa Giovanni XXIII, Vall d'Hebron Hospital Universitari, The Royal Melbourne Hospital, Peter MacCallum Cancer Centre, IRCCS Humanitas Research Hospital, University of Copenhagen, Rigshospitalet, Groupe de Recherche sur les formes Injectables et les Technologies Associées
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409631484
